Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

University of Alberta

$688,026.00

The Role of AMPK in the Regulation of Cardiac Hypertrophy and Hypertension

EF 2009-10

Résumé
Heart failure is a major cause of death worldwide and occurs as a consequence of a number of diseases related to the heart or to the blood vessels. A common condition that can lead to heart failure is abnormal heart muscle growth. We have identified a new pathway that contributes to abnormal heart growth as well as found a drug that can rescue this pathway and prevent this condition. In addition to the direct effects on the heart, this pathway also contributes to elevated blood pressure. As a result, we will perform pre-clinical studies using rats and mice to determine how this drug alters the aforementioned pathways to prevent a rise in blood pressure and abnormal heart growth. Since abnormal heart growth and high blood pressure are major risk factors for the development of a number of other heart related illnesses, understanding how our newly identified pathway is involved in these diseases will contribute significantly to understanding abnormal heart growth and high blood pressure. In addition, studying how our drug regulates this pathway to prevent these diseases could one day lead to this drug being used clinically.
Programme
Operating Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
198977
Name
Dyck Jason R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Cardiovascular System - A: Cells and Tissues
Projecttitle
The Role of AMPK in the Regulation of Cardiac Hypertrophy and Hypertension
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$688,026
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Ampk; Animal Models Of Disease; Cardiac Hypertrophy; Cell Signalling; Hypertension; Resveratrol
Abstract
Heart failure is a major cause of death worldwide and occurs as a consequence of a number of diseases related to the heart or to the blood vessels. A common condition that can lead to heart failure is abnormal heart muscle growth. We have identified a new pathway that contributes to abnormal heart growth as well as found a drug that can rescue this pathway and prevent this condition. In addition to the direct effects on the heart, this pathway also contributes to elevated blood pressure. As a result, we will perform pre-clinical studies using rats and mice to determine how this drug alters the aforementioned pathways to prevent a rise in blood pressure and abnormal heart growth. Since abnormal heart growth and high blood pressure are major risk factors for the development of a number of other heart related illnesses, understanding how our newly identified pathway is involved in these diseases will contribute significantly to understanding abnormal heart growth and high blood pressure. In addition, studying how our drug regulates this pathway to prevent these diseases could one day lead to this drug being used clinically.
Competitiondate
201003
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Dyck, Jason R
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $688,026~ $0~